LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 86 filers reported holding LOXO ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $217,000 | +48.6% | 6,729 | +20.7% | 0.00% | – |
Q3 2016 | $146,000 | +24.8% | 5,574 | +9.7% | 0.00% | – |
Q2 2016 | $117,000 | -15.8% | 5,079 | -35.9% | 0.00% | – |
Q3 2015 | $139,000 | -2.8% | 7,924 | 0.0% | 0.00% | – |
Q2 2015 | $143,000 | +88.2% | 7,924 | +29.4% | 0.00% | – |
Q1 2015 | $76,000 | +5.6% | 6,122 | 0.0% | 0.00% | – |
Q4 2014 | $72,000 | – | 6,122 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |